Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06175832
PHASE4

PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study

Sponsor: University Hospital, Ghent

View on ClinicalTrials.gov

Summary

P-CCROSS is a randomized, prospective monocentric phase 4 study with a crossover study design. The aim of the study is to compare patient satisfaction (by means of questionnaires) and treatment compliance with IVF treatment with CFA (corifollitropin alfa) and PPOS (Progestin-Primed Ovarian Stimulation) versus conventional IVF treatment with a recombinant FSH/GnRH antagonist. The study will also compare patients undergoing elective fertility preservation versus PGT-A (pre-implantation genetic testing for aneuploidy) patients.The study will have a crossover design so that patients will receive both forms of treatment. The investigators will also compare the endocrine profile and ovarian response of CFA/PPOS versus rFSH/GnRH ovarian stimulation cycles.

Official title: PPOS and CFA for Elective Freeze-all Ovarian Stimulation Cycles: a Prospective Cross-over Study

Key Details

Gender

FEMALE

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-01-27

Completion Date

2027-12-31

Last Updated

2025-12-26

Healthy Volunteers

No

Interventions

DRUG

Elonva®

Single injection

DRUG

Puregon®

Multiple injections

DRUG

Orgalutran®

Multiple injections

DRUG

Gonapeptyl®

Double injection

DRUG

Cerazette®

Oral tablet

Locations (1)

University Hospital Ghent

Ghent, Belgium